Physician profile
Sameer Chopra
NPI 1831630037
$9,160.95
in general payments reported to CMS, 2019-2025
42 companies · $2,175 in 2025
The $2,175 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $569 · 2022: $536 · 2023: $3,510 · 2024: $2,371 · 2025: $2,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,055.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,669.39 | 2021-2025 | Ams 700, Ams 700 Cxr Rte Kit, Bulkamid |
| Medtronic, INC. | $1,632.76 | 2022-2025 | Interstim |
| Teleflex LLC | $989.70 | 2022-2025 | Urolift, Solesta, Deflux Metal Needle |
| Axonics, INC. | $910.60 | 2023-2024 | Bulkamid, Axonics |
| Procept Biorobotics Corporation | $518.93 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Calyxo, INC. | $484.23 | 2023-2025 | Cvac Aspiration System |
| Palette Life Sciences, INC. | $245.02 | 2023 | |
| Angiodynamics, INC. | $216.94 | 2025 | Nanoknife |
| Endo Pharmaceuticals INC. | $210.63 | 2023-2024 | Xiaflex, Aveed, Edex |
| Myriad Genetic Laboratories, INC. | $192.35 | 2023-2024 | Prolaris |
| Agiliti Surgical, INC. | $180.46 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Merck Sharp & Dohme LLC | $147.15 | 2023-2025 | Keytruda |
| Sumitomo Pharma America, INC. | $140.86 | 2023-2025 | Gemtesa |
| Bard Peripheral Vascular, INC. | $136.66 | 2024 | Model 200 Theraseed Palladium-103 In Readylink |
| Myovant Sciences INC. | $125.00 | 2021 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $125.00 | 2023 | Erleada |
| Lilly USA, LLC | $121.91 | 2022 | |
| Pfizer INC. | $109.47 | 2024 | |
| Allergan, INC. | $105.18 | 2021 | |
| Olympus America INC. | $102.16 | 2025 | Itind System |
| Blue Earth Diagnostics | $98.65 | 2023 | |
| Endo USA, INC. | $95.51 | 2025 | Xiaflex, Aveed |
| Coloplast Corp | $78.05 | 2023-2024 | Speedicath |
| Abbvie INC. | $50.64 | 2023-2025 | Botox |
| Bluewind Medical | $49.19 | 2024 | |
| Bioprotect Medical, INC. | $43.89 | 2025 | Bioprotect Balloon Implant System |
| Laborie Medical Technologies Corp. | $41.26 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Intuitive Surgical, INC. | $39.89 | 2024 | |
| Ambu INC. | $32.41 | 2025 | |
| 180 Medical, INC. | $28.73 | 2023 | Gentlecath Glide |
| Tolmar, INC. | $26.37 | 2023 | |
| Histosonics, INC. | $26.31 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $25.13 | 2023 | Seglentis |
| Convatec INC. | $22.18 | 2023 | |
| Integra Lifesciences Corporation | $21.07 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Astrazeneca Pharmaceuticals Lp | $19.85 | 2023 | |
| Profound Medical Corp. | $17.78 | 2025 | Tulsa-Pro |
| C. R. Bard, INC. & Subsidiaries | $17.71 | 2025 | Bard Urinary Drainage Bag |
| Immunitybio, INC. | $17.43 | 2025 | |
| Srs Medical Systems, INC. | $17.42 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Accord Healthcare, INC. | $13.61 | 2024 | |
| Photocure INC | $13.47 | 2023 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.